SCHEMBL6312682

SCHEMBL6312682

CCOC(=O)c1cc(N=C=O)on1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
MAPT P10636 7/20 0.43
CYP1A2 P05177 1/20 0.42
ALDH1A1 P00352 4/20 0.39
GABRP O00591 1/20 0.39
GABRD O14764 1/20 0.39
GABRA1 P14867 1/20 0.39
GABRB1 P18505 1/20 0.39
GABRG2 P18507 1/20 0.39
GABRB3 P28472 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRB2 P47870 1/20 0.39
GABRA4 P48169 1/20 0.39
GABRE P78334 1/20 0.39
GABRA6 Q16445 1/20 0.39
GABRG1 Q8N1C3 1/20 0.39
GABRG3 Q99928 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6317905 0.83 MAPT (0.44) MAPTCYP1A2ALDH1A1TP53HPGD
SCHEMBL434805 0.79 MEN1 (0.61) MEN1KMT2AMAPTCYP1A2ALDH1A1
SCHEMBL6317015 0.75 CYP1A2 (0.41) MEN1KMT2AMAPTCYP1A2ALDH1A1
SCHEMBL31286841 0.74 CYP1A2 (0.50) MEN1KMT2AMAPTCYP1A2ALDH1A1
SCHEMBL162619 0.74 CYP1A2 (0.50) MEN1KMT2AMAPTCYP1A2ALDH1A1
SCHEMBL2190095 0.73 MEN1 (0.52) MEN1KMT2AMAPTCYP1A2ALDH1A1
SCHEMBL15640906 0.72 CYP1A2 (0.49) MEN1KMT2AMAPTCYP1A2ALDH1A1
SCHEMBL4478920 0.72 CYP1A2 (0.49) MEN1KMT2AMAPTCYP1A2ALDH1A1
SCHEMBL892581 0.72 MAPT (0.50) MEN1KMT2AMAPTCYP1A2ALDH1A1
SCHEMBL21523835 0.72 ALDH1A1 (0.49) MEN1KMT2AMAPTCYP1A2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143581-A1 Process for preparation of alkoxybenzamides and thiazolyl isocyanates MITSUI CHEMICALS, INC. (JP) 2005-06-30 US disclosed
EP-1489073-A1 PROCESS FORPREPARATION OF ALKOXYBENZAMIDES AND THIAZOLYL ISOCYANATES MITSUI CHEMICALS, INC. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143581-A1 Process for preparation of alkoxybenzamides and thiazolyl isocyanates CBR3, CBR1, IDH1 MEN1 4369/4885KMT2A 613/4885MAPT 3828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.